After Rs 1.2 lakh crore FII outflow, CLSA shifts focus back to India from China
CLSA reverses its investment shift from India to China, citing economic concerns in China, trade tensions, and rising U.S.
Precigen, Inc.: Precigen Reports Third Quarter 2024 Financial Results and Business Updates
Completed pre-BLA meeting with FDA with full alignment on content of BLA, including CMC module, and path for fourth quarter 2024 rolling BLA submission for PRGN-2012† ...
Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update
The PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial is 100% enrolled; expect to report topline data for this cohort in late Q1 2025 or Q2 2025Approximately $264 million in cash, cash equivalen ...